Bio-Path (BPTH) Institutional Ownership $0.16 +0.02 (+10.00%) As of 04/17/2025 03:55 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Bio-Path (NASDAQ:BPTH)CurrentInstitutional OwnershipPercentage5.74%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$194KNumber ofInstitutional Sellers(last 12 months)0 Get BPTH Insider Trade Alerts Want to know when executives and insiders are buying or selling Bio-Path stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BPTH Institutional Buying and Selling by Quarter Bio-Path Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024Armistice Capital LLC97,000$194K0.0%N/A4.663% 11/7/2022Virtu Financial LLC12,090$39K0.0%N/A0.169% 11/7/2022 Mount Yale Investment Advisors LLC25,350$81K0.0%N/A0.354% 2/10/2022Bailard Inc.33,521$126K0.0%N/A0.468% 8/16/2021State Street Corp12,133$81K0.0%N/A0.174% 8/13/2021Northern Trust Corp17,744$119K0.0%N/A0.255% 8/13/2021Geode Capital Management LLC65,353$435K0.0%+15.5%0.939% 8/13/2021Vanguard Group Inc.218,992$1.46M0.0%+76.2%3.146% 8/12/2021Dimensional Fund Advisors LP28,148$188K0.0%+58.8%0.404% 5/21/2021Citadel Advisors LLC20,591$145K0.0%N/A0.296% 5/18/2021Citadel Advisors LLC20,591$145K0.0%N/A0.296% 5/14/2021Dimensional Fund Advisors LP17,725$124K0.0%N/A0.255% 5/13/2021Renaissance Technologies LLC73,800$518K0.0%-4.9%1.062% 5/12/2021Geode Capital Management LLC56,590$397K0.0%+65.5%0.814% (Data available from 1/1/2016 forward) BPTH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BPTH shares? During the previous two years, the following institutional investors and hedge funds held shares of Bio-Path shares: Armistice Capital LLC ($194K).Learn more on BPTH's institutional investors. What percentage of Bio-Path stock is owned by institutional investors? 5.74% of Bio-Path stock is owned by institutional investors. Learn more on BPTH's institutional investor holdings. Which institutional investors have been buying Bio-Path stock? The following institutional investors have purchased Bio-Path stock in the last 24 months: Armistice Capital LLC ($97K). How much institutional buying is happening at Bio-Path? Institutional investors have bought a total of 97,000 shares in the last 24 months. This purchase volume represents approximately $194K in transactions. Related Companies SXTP Major Shareholders ADIL Major Shareholders NCNA Major Shareholders CANF Major Shareholders PWUP Major Shareholders MBIO Major Shareholders ONCO Major Shareholders ATNF Major Shareholders DRMA Major Shareholders AEON Major Shareholders This page (NASDAQ:BPTH) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Path Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Path With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BPTH Stock Free BPTH Stock Alerts